Profiting On Rare-Use Devices: FDA Updates HDE Guidelines
This article was originally published in The Gray Sheet
An FDA draft guidance issued March 17 incorporates changes to the HDE program enacted by the FDA Safety and Innovation Act of 2012, including a profit allowance for certain non-pediatric indications.
You may also be interested in...
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.